MENU
OZEM
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

OZEM stock forecast, quote, news & analysis

The investment seeks to provide capital appreciation... Show more

Category: #Health
OZEM
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for OZEM with price predictions
Jul 31, 2026

OZEM's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for OZEM moved out of overbought territory on July 08, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 instances where the indicator moved out of the overbought zone. In of the 18 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OZEM as a result. In of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OZEM turned negative on July 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 22 similar instances when the indicator turned negative. In of the 22 cases the stock turned lower in the days that followed. This puts the odds of success at .

OZEM moved below its 50-day moving average on July 31, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OZEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 22 cases where OZEM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for OZEM crossed bullishly above the 50-day moving average on June 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OZEM advanced for three days, in of 147 cases, the price rose further within the following month. The odds of a continued upward trend are .

OZEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 103 cases where OZEM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Market Cap

The average market capitalization across the Roundhill GLP-1 & Weight Loss ETF ETF is 121.14B. The market cap for tickers in the group ranges from 199.3M to 1.02T. LLY holds the highest valuation in this group at 1.02T. The lowest valued company is KROS at 199.3M.

High and low price notable news

The average weekly price growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 0%. For the same ETF, the average monthly price growth was 0%, and the average quarterly price growth was -9%. CORT experienced the highest price growth at 20%, while VKTX experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 60%. For the same stocks of the ETF, the average monthly volume growth was 7% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 41
P/E Growth Rating: 74
Price Growth Rating: 47
SMR Rating: 71
Profit Risk Rating: 67
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
OZEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
OZEM's RSI Indicator peaks and leaves overbought zone